The World Health Organization requested further information from India’s Bharat Biotech on Monday to examine the company’s request for an emergency-use designation for its COVID-19 injection, stating that the WHO could not “take shortcuts” in making a judgment.
Bharat Biotech, which collaborated with an Indian governmental research entity to produce Covaxin, began sharing data with the WHO in early July. Even before the end of a late-stage trial, which found the vaccination to be 78 percent effective, the vaccine was given emergency use authorization in India in January.
Discussion about this post